Find Research Projects

Search results

• CON- Chung Commitments

  Chung, J.

  10/1/15 → 9/30/24

  Project: Other project

• Nrf2 activation for addiction-free treatment of neuropathic pain

  Dineley, K.

  9/30/19 → 9/30/24

  Project: Other project

• CON- Chung Commitments

  Chung, J.

  10/1/15 → 9/30/24

  Project: Other project

• CON- Chung Commitments

  Chung, J.

  10/1/15 → 9/30/24

  Project: Other project

• CON- Chung Commitments

  Chung, J.

  10/1/15 → 9/30/24

  Project: Other project

• Master Agreement W18-KP-UTMB

  Powers, W.

  11/8/18 → 9/30/24

  Project: Other project

• Master Agreement W18-KP-UTMB

  Powers, W.

  11/8/18 → 9/30/24

  Project: Other project

• Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)

  Anderson, K.

  10/6/21 → 10/5/24

  Project: Other project

• Prevention of Preterm Birth Biomarker Summit and Global Workshop

  Menon, R.

  11/1/20 → 10/31/24

  Project: Other project

• Prevention of Preterm Birth Biomarker Summit and Global Workshop

  Menon, R.

  Hologic Incorporated

  11/1/20 → 10/31/24

  Project: Other project

• (OHANA MIRUM VLX-401) A Phase 2a/2b Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in Adult Women with Intrahepatic Cholestasis of Pregnancy and Elevated Serum Bile Acid Concentrations

  Saade, G.

  Mirum Pharmaceuticals

  11/12/20 → 11/11/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  12/1/19 → 11/30/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  National Cancer Institute

  12/1/19 → 11/30/24

  Project: Other project

• Functional genomic dissection of breast cancer drug-induced cardiotoxicity in an iPSC model

  Ward, M.

  12/1/19 → 11/30/24

  Project: Other project

• Functional genomic dissection of breast cancer drug-induced cardiotoxicity in an iPSC model

  Ward, M.

  12/1/19 → 11/30/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  12/1/19 → 11/30/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  12/1/19 → 11/30/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  12/1/19 → 11/30/24

  Project: Other project

• Next Generation Multipurpose Intravaginal Ring Technology Using Innovative CLIP 3D Printing

  Vincent, K.

  University of N Carolina at Chapel Hill

  12/1/19 → 11/30/24

  Project: Other project

• Bimodal Intraoral imaging device for detection of oral epithelial neoplasia

  Vargas, G.

  National Cancer Institute

  12/1/19 → 11/30/24

  Project: Other project

• Next Generation Multipurpose Intravaginal Ring Technology Using Innovative CLIP 3D Printing

  Vincent, K.

  12/1/19 → 11/30/24

  Project: Other project

• Regulation of lung cancer survival and metastasis by an actionable driver of vesicle biogenesis in the Golgi

  Russell, W.

  University of Texas M D Anderson Cancer

  12/1/19 → 11/30/24

  Project: Other project

• (ELITE-Medtronic) Evaluation of InterStim Micro System Performance and Safety (ELITE) to Confirm Long-Term Outcomes

  Yaklic, J.

  Medtronic Inc

  12/14/20 → 12/13/24

  Project: Other project

• Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis for Cesarean Delivery (C/SOAP Follow-up Study II)

  Saade, G.

  University of Alabama-Birmingham

  1/20/20 → 12/31/24

  Project: Other project

• CAPITATION: Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis for Cesarean Delivery (C/SOAP Follow-up Study II)

  Saade, G.

  University of Alabama-Birmingham

  1/20/20 → 12/31/24

  Project: Other project

• Mechanistic Function of HCV NS5A Targeted by Potent Inhibitors

  Yi, M. K.

  2/1/20 → 1/31/25

  Project: Other project

• Polycyclic aromatic hydrocarbons; Ultrasensitive detection, early life exposures-clinical outcomes (preterm births, chronic lung disease, and neurocognitive deficits), prevention and remediation

  Croisant, S.

  BAYLOR COLLEGE OF MEDICINE

  2/28/20 → 1/31/25

  Project: Other project

• Mechanistic Function of HCV NS5A Targeted by Potent Inhibitors

  Yi, M. K.

  2/1/20 → 1/31/25

  Project: Other project

• Polycyclic aromatic hydrocarbons; Ultrasensitive detection, early life exposures-clinical outcomes (preterm births, chronic lung disease, and neurocognitive deficits), prevention and remediation

  Croisant, S.

  2/28/20 → 1/31/25

  Project: Other project

• Mechanistic Function of HCV NS5A Targeted by Potent Inhibitors

  Yi, M. K.

  National Inst of Allergy & Infectious Di

  2/1/20 → 1/31/25

  Project: Other project

• Mechanistic Function of HCV NS5A Targeted by Potent Inhibitors

  Yi, M. K.

  2/1/20 → 1/31/25

  Project: Other project

• A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

  Rupp, R.

  2/12/20 → 2/11/25

  Project: Other project

• A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

  Rupp, R.

  2/12/20 → 2/11/25

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.

  Cohn, S.

  Eli Lilly

  2/27/20 → 2/26/25

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis.

  Cohn, S.

  2/27/20 → 2/26/25

  Project: Other project

• Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

  Menon, R.

  3/12/20 → 2/28/25

  Project: Other project

• Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

  Ikegami, T.

  National Inst of Allergy & Infectious Di

  3/10/20 → 2/28/25

  Project: Other project

• Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

  Ikegami, T.

  3/10/20 → 2/28/25

  Project: Other project

• Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

  Menon, R.

  3/12/20 → 2/28/25

  Project: Other project

• Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

  Ikegami, T.

  National Inst of Allergy & Infectious Di

  3/10/20 → 2/28/25

  Project: Other project

• Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

  Menon, R.

  National Inst of Child Health & Human De

  3/12/20 → 2/28/25

  Project: Other project

• Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis

  Menon, R.

  3/12/20 → 2/28/25

  Project: Other project

• Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

  Ikegami, T.

  3/10/20 → 2/28/25

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  Pfizer, Inc.

  3/11/21 → 3/10/25

  Project: Other project

• A Phase 3 Randomized, Observer-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of the Vaccine Candidate BNT162b2 Against COVID-19 in Healthy Adults 18 through 55 years of Age.

  Rupp, R.

  3/11/21 → 3/10/25

  Project: Other project

• Medical Services and Support For the NSF Antarctic Support Contract

  McCallum, R.

  Lockheed Martin

  3/31/12 → 3/30/25

  Project: Other project

• Medical Services and Support For the NSF Antarctic Support Contract

  McCallum, R.

  Lockheed Martin

  3/31/12 → 3/30/25

  Project: Other project

• Medical Services and Support For the NSF Antarctic Support Contract

  McCallum, R.

  3/31/12 → 3/30/25

  Project: Other project

• Polar Ops Clearing Account

  McCallum, R.

  3/31/12 → 3/30/25

  Project: Other project

• Medical Services and Support For the NSF Antarctic Support Contract

  McCallum, R.

  Lockheed Martin

  3/31/12 → 3/30/25

  Project: Other project